PlatformHealthcare
1315 Capital Acquires Aluris Sciences
The carved-out business provides contract manufacturing for life sciences, diagnostics and combination drug products.
- Target
- Aluris Sciences
- Sponsor
- 1315 Capital
- Source
- Business Wire
Most recent deal Wednesday, September 9, 2026.
The carved-out business provides contract manufacturing for life sciences, diagnostics and combination drug products.